Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04776161 · ClinicalTrials.gov registry record · NA

Medication Adherence Patterns in Rheumatic Diseases: A Behavioral Trial

A NA study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
62
Enrollment target

NCT04776161 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 62 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04776161, a NA study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
62 participants
Enrollment target

Study Summary

Non-adherence to evidence-based prescription medications results in preventable morbidity and mortality for middle-aged and older adults. Taking medications intended for daily use, like those to prevent or treat chronic conditions, is a repetitive action that has great similarity with other behaviors that must be performed consistently, such as regular exercise, healthy eating, and hand washing. In these cases, people who act consistently do so out of habit. The "repetition-cue-reward" model proposes that habit formation has three central components: behavioral repetition, associated context cues, and rewards. This model has obvious applicability to the daily repetitive activity of medication-taking but has not been tested for this behavior nor adapted as an intervention for patients in real-world care settings. The goal of this pilot study is to evaluate the feasibility and effectiveness of using the repetition-cue-reward model of healthy habit formation to improve medication adherence in patients with arthritis and other rheumatic diseases.

Interventions

  • BEHAVIORAL Cue-Reward Intervention
  • BEHAVIORAL Cue-Reward Intervention with possible intensification

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2021-08-02
Est. Completion 2022-11-10
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT04776161

The ClinicalTrials.gov registry entry for NCT04776161 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Cue-Reward Intervention is the first listed.

NCT04776161 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04776161 about?

NCT04776161 is a clinical study titled "Medication Adherence Patterns in Rheumatic Diseases: A Behavioral Trial". Non-adherence to evidence-based prescription medications results in preventable morbidity and mortality for middle-aged and older adults. Taking medications intended for daily use, like those to prevent or treat chronic conditions, is a repetitive action that has great similarity with other behavior...

What is the current status of trial NCT04776161?

This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2021-08-02. Estimated completion is 2022-11-10.

What interventions are being tested in trial NCT04776161?

The interventions under investigation include: Cue-Reward Intervention (BEHAVIORAL), Cue-Reward Intervention with possible intensification (BEHAVIORAL).

Who is sponsoring clinical trial NCT04776161?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.